A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients

• Status: Completed
• Trial end date: 2016-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

Randomized controlled single blind prospective comparative study

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Ibadan
• Treatments: Azithromycin; Fanasil, pyrimethamine drug combination; Pyrimethamine; Sulfadoxine

Criteria

Inclusion Criteria:

• Pregnant HIV positive patients,

• Gestational age 16 weeks and above,

• No history of azithromycin or sulphadoxine-pyrimethamine use four weeks prior to recruitment

Exclusion Criteria:

• Anaemia packed cell volume less than 30%,

• pre-existing medical conditions- diabetes mellitus,

• hypertension,

• allergy to sulphadoxine-pyrimethamine or azithromycin